Prof. Xiaomao Guo 郭小毛
Chief Physician, Professor
Medical Oncology, Shanghai Proton and Heavy Ion Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation and comprehensive treatment for breast tumors, abdominal tumors, prostate cancer, and malignant lymphoma.
Dr. Guo is Party Secretary of Fudan University Shanghai Cancer Center and Dean of Shanghai Proton and Heavy Ion Center. A doctoral supervisor, Dr. Guo graduated from Shanghai Medical University in 1993. Research focuses on radiation therapy for breast, abdominal, prostate, and lymphoma cancers. Dr. Guo has led National Natural Science Foundation projects, received a first-class Ministry of Education science progress award, and published over 60 papers.
Professional roles
- Standing Committee Member, Chinese Medical Association
- Vice Chair, Oncology Branch of Chinese Medical Doctor Association
- Executive Director, China Anti-Cancer Association
- Vice Chair, Radiation Oncology Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Guo Xiaomao). Papers usually list the name as Xiaomao Guo or Guo X.
Selected publications
18 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Med Phys, 2026 (senior author): Prediction of radiation-induced hypothyroidism after proton-based supraclavicular nodal irradiation in breast cancer. PubMed 42875928
- Front Public Health, 2021 (senior author): Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer. PubMed 34950631
- Med Sci Monit, 2017 (senior author): Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells. PubMed 28570501
- J Cancer Res Ther, 2016 (senior author): Incidence and risk of hypertension associated with ramucirumab in cancer patients: A systematic review and meta-analysis. PubMed 27461650
- Crit Rev Oncol Hematol, 2015 (senior author): Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials. PubMed 25749417
- Radiother Oncol, 2015 (senior author): Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis. PubMed 25497556
- Curr Med Res Opin, 2015 (senior author): Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials. PubMed 25329826
- BMC Med, 2014 (senior author): Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysis. PubMed 25369798
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion